BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10691540)

  • 1. Oversight mechanisms for clinical research.
    Snyderman R; Holmes EW
    Science; 2000 Jan; 287(5453):595-7. PubMed ID: 10691540
    [No Abstract]   [Full Text] [Related]  

  • 2. Shutdown of research at Duke sends a message.
    Marshall E
    Science; 1999 May; 284(5418):1246. PubMed ID: 10383299
    [No Abstract]   [Full Text] [Related]  

  • 3. Research ethics. NIH examines standards for consent.
    Marshall E
    Science; 1998 Jun; 280(5370):1688. PubMed ID: 9660706
    [No Abstract]   [Full Text] [Related]  

  • 4. Duke's hazards. Did medical experiments put patients needlessly at risk?
    Kaplan S; Brownlee S
    US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890
    [No Abstract]   [Full Text] [Related]  

  • 5. Waivers proposed for emergency studies.
    Wolfgang L
    Science; 1995 Oct; 270(5233):25-6. PubMed ID: 7569946
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomedical ethics. HHS plans to overhaul clinical research rules.
    Marshall E
    Science; 2000 May; 288(5470):1315-6. PubMed ID: 10847836
    [No Abstract]   [Full Text] [Related]  

  • 7. Panel faults research consent process.
    Marshall E
    Science; 1995 Oct; 270(5233):25. PubMed ID: 7569945
    [No Abstract]   [Full Text] [Related]  

  • 8. The Office for Protection from Research Risks.
    Porter JP
    Kennedy Inst Ethics J; 1992 Sep; 2(3):279-82. PubMed ID: 10121091
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting research subjects--what must be done.
    Shalala D
    N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
    [No Abstract]   [Full Text] [Related]  

  • 10. IRBs search for answers and support during a time of institutional change.
    Phillips DF
    JAMA; 2000 Feb; 283(6):729-30. PubMed ID: 10683041
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved protection for human research subjects.
    Marwick C
    JAMA; 1998 Feb; 279(5):344-5. PubMed ID: 9459454
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomedical ethics. Penn report, agency heads home in on clinical research.
    Marshall E
    Science; 2000 Jun; 288(5471):1558-9. PubMed ID: 10858125
    [No Abstract]   [Full Text] [Related]  

  • 13. Keeping research subjects out of harm's way.
    Ellis GB
    JAMA; 1999 Nov; 282(20):1963-5. PubMed ID: 10580465
    [No Abstract]   [Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical ethics. Principles for human gene therapy studies.
    Friedmann T
    Science; 2000 Mar; 287(5461):2163-5. PubMed ID: 10744537
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal judgments and informed consent in geriatric research.
    Dubler NN
    J Am Geriatr Soc; 1987 Jun; 35(6):545-9. PubMed ID: 3571807
    [No Abstract]   [Full Text] [Related]  

  • 17. NIH ethics office clamps down on Duke...as basic scientists feel the pinch in LA.
    Wadman M
    Nature; 1999 May; 399(6733):190. PubMed ID: 10353232
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on Waiving Informed Consent in Emergency Research.
    McCarthy CR
    Kennedy Inst Ethics J; 1995 Dec; 5(4):385-6. PubMed ID: 10153763
    [No Abstract]   [Full Text] [Related]  

  • 19. Lay participation in medical policy making. II. Human experimentation committees: professional or representative?
    Veatch RM
    Hastings Cent Rep; 1975 Oct; 5(5):31-40. PubMed ID: 1184371
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA gets feedback on informed consent waiver.
    Marwick C
    JAMA; 1996 Feb; 275(5):347. PubMed ID: 8568998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.